Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Grace Therapeutics, Inc. (GRCE) had Operating Cash Flow per Share of $-1.23 for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-9.57M |
|
-- |
|
-- |
|
$16.68M |
|
$-16.68M |
|
$3.91M |
|
$-12.77M |
|
$-12.77M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-9.57M |
|
$-16.68M |
|
$-16.67M |
|
12.09M |
|
12.09M |
|
$-0.79 |
|
$-0.79 |
|
| Balance Sheet Financials | |
$22.71M |
|
$0.01M |
|
$49.28M |
|
$71.99M |
|
$1.93M |
|
-- |
|
$3.45M |
|
$5.38M |
|
$66.61M |
|
$17.34M |
|
$66.61M |
|
13.72M |
|
| Cash Flow Statement Financials | |
$-14.90M |
|
-- |
|
$14.03M |
|
$23.00M |
|
$22.13M |
|
$-0.87M |
|
$0.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.36% |
|
-55.17% |
|
-13.29% |
|
-14.36% |
|
$4.86 |
|
$-1.23 |
|
|
Operating Cash Flow per Share |
$-1.23 |